C. Codreanu *, Alina Rădulescu *, Deana Ganea *, D. Barsila *
* C. Codreanu, Alina Rădulescu, Ileana Ganea, D. Barsila – Centrul de Boli Reumatismale București
Abstract
Poliarthritic rheumatoid is a disease autoimune with unknown etiology defined through erosive symmetrical sinovitis and sometimes polisystemic affectation . Majority patients present a chronic fluctuant evolution which untreated conducts to progressively autoimune disfunction, articular permanent deformations attend to motor deficiency and reducing the lifehopes Based on understunding of molecular mechanisms of disease, infliximab(Remicade) opens a new age in therapy of rheumatoid arthrites. This product inducts a quick improvement evolutions of disease, improve the quality life patients and exercise an unique effect of stops the progressions of disease